Novo Nordisk Sees Retail Buying Despite Wall Street Cuts

Mitrade
Updated
coverImg
Source: DepositPhotos

Insights – Shares of leading weight-loss drugmaker Novo Nordisk plunged after disappointing results from its latest weight-loss drug trial. Despite analysts slashing their price targets, retail investors flooded into the stock with massive buy-the-dip activity.  


According to data from Vanda Research, retail inflows into Novo Nordisk surged 32-fold on Friday, December 20. The single-day net inflow jumped from $490,000 the previous day to $15.6 million.  


Marco Iachini, Senior Vice President at Vanda Research, noted that retail investors tend to buy the dip, particularly in popular stocks, and added that they would continue doing so until the strategy ceased to be effective.


Novo Nordisk’s December 20 trial results revealed that its next-generation weight-loss drug, CagriSema, achieved only a 22.7% weight loss effect after eight weeks of treatment, falling short of the market expectation of 25%.  


The company’s previous flagship weight-loss drug, Wegovy, had set high standards, and Novo Nordisk had hoped CagriSema would outperform its main competitor, Eli Lilly’s (LLY.US) Zepbound. However, the underwhelming trial results sent Novo Nordisk shares tumbling 17.83% on the day, while Eli Lilly’s stock ended a multi-day decline, rising 1.35%.  


Following the trial results, Wall Street analysts sharply lowered their price targets for Novo Nordisk.BMO Capital** cut its target from $156 to $105.  TD Cowen** reduced its target from $155 to $105.  Jefferies downgraded its target to $81.50 and maintained a "Sell" rating.  


As of the latest close, Novo Nordisk shares traded at $87.37, representing a year-to-date decline of 15.54%.  




* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
Nio faces Singapore lawsuit for alleged revenue manipulation as shares plungeNio is being sued by Singapore’s GIC for allegedly inflating over $600 million in revenue through a hidden affiliate.
Author  Cryptopolitan
6 hours ago
Nio is being sued by Singapore’s GIC for allegedly inflating over $600 million in revenue through a hidden affiliate.
placeholder
TSMC Q3 Net Profit Surges 39% to Record High on Booming AI Demand, HPC Contributes Over Half of RevenueTSMC reported its third-quarter financial results, with net profit soaring 39% year-on-year to a record NT$452.3 billion, significantly beating market expectations of NT$405.47 billion.
Author  TradingKey
6 hours ago
TSMC reported its third-quarter financial results, with net profit soaring 39% year-on-year to a record NT$452.3 billion, significantly beating market expectations of NT$405.47 billion.
placeholder
Wall Street’s Q3 Earnings Shine, But Red Flags Flash as Non-Bank Lending GrewStrong third-quarter results from major Wall Street banks have kicked off the 2025 earnings season on a high note, with JPMorgan Chase posting record revenue, and Goldman Sachs and Citi delivering their best Q3 ever.
Author  TradingKey
Yesterday 09: 50
Strong third-quarter results from major Wall Street banks have kicked off the 2025 earnings season on a high note, with JPMorgan Chase posting record revenue, and Goldman Sachs and Citi delivering their best Q3 ever.
placeholder
Metaplanet’s Market Value Slides Below Bitcoin HoldingsMetaplanet’s valuation metric, mNAV, briefly dipped below 1.0, signaling a market discount relative to its Bitcoin assets.
Author  Beincrypto
Yesterday 05: 47
Metaplanet’s valuation metric, mNAV, briefly dipped below 1.0, signaling a market discount relative to its Bitcoin assets.
placeholder
TSMC Q3 Earnings Preview: Record Revenue Is a Lock, but an Upgraded Outlook Could Be the Real CatalystGlobal semiconductor foundry leader Taiwan Semiconductor Manufacturing Company (TSMC, TSM) will report its Q3 2025 earnings on Thursday, October 16, before U.S. markets open.
Author  TradingKey
Oct 14, Tue
Global semiconductor foundry leader Taiwan Semiconductor Manufacturing Company (TSMC, TSM) will report its Q3 2025 earnings on Thursday, October 16, before U.S. markets open.